ABSI

Absci Corporation Common Stock

$8.74

Current Price

All

AI analysis

Read what the AI thinks of Absci Corporation Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.80

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.21

Nov 12

Posts

No posts about ABSI yet.

About Absci Corporation Common Stock

Absci is a biotechnology company that uses artificial intelligence to design new antibody drugs, which are proteins that help the body fight disease. It earns small amounts of revenue from research partnerships with larger drug makers, and it is developing its own drug candidates that could bring much larger payoffs if they succeed in trials and reach the market.